Tag

NASDAQ: WVE

Wave Life Sciences plans two‑year WVE‑006 trial after FDA feedback
Adrian Kessler · Oct 1, 2026
Wave Life Sciences brings big biotech breakthrough with RNA editing therapy
Joseph Morton · Oct 16, 2024
Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy
Joseph Morton · Sep 24, 2024